Yesterday brought an exciting announcement from pharmaceutical company sanofi-aventis; Sculptra has been FDA cleared for physicians to use in additional facial cosmetic procedures. Even though off-label cosmetic use of Sculptra is common and has been happening for years, original approval of the filler was for treating lipoatrophy, i.e. facial fat loss, in AIDS patients. Professionals […]
Researchers associated with the American Society for Aesthetic Plastic Surgery (ASAPS) sent questionnaires last March to 687 patients who had received Botox and/or dermal filler treatment. The findings offer some insight about the treatments and the patients who choose them. The following figures illustrate the opinions of the ‘typical’ patient. Who is the ‘typical’ patient? […]
Dysport, the new wrinkle treatment from Medicis, has received FDA approval for treating wrinkles and dystonia. Plastic surgeons and dermatologists could have the drug available in just 3o days. Instead of re-branding the drug ‘Reloxin’ as planned, Medicis Pharmaceutical had to retain its original European name. Along with the April 30th announcement came a 3 […]